tradingkey.logo

IQVIA Holdings Inc

IQV
220.880USD
+2.350+1.08%
收盤 11/12, 16:00美東報價延遲15分鐘
37.62B總市值
29.32本益比TTM

IQVIA Holdings Inc

220.880
+2.350+1.08%

關於 IQVIA Holdings Inc 公司

IQVIA Holdings Inc. 是生命科學行業高級分析、技術解決方案和臨牀研究服務提供商。其部門包括技術與分析解決方案、研發解決方案和合同銷售與醫療解決方案。技術與分析解決方案部門爲其生命科學客戶提供關鍵任務信息、技術解決方案和現實世界的見解和服務。研發解決方案部門爲生物製藥客戶提供服務,並提供外包臨牀研究和臨牀試驗相關服務。合同銷售與醫療解決方案部門爲生物製藥客戶和更廣泛的醫療保健市場提供醫療保健提供商(包括合同銷售)和患者參與服務。其 Connected Intelligence 提供見解和解決方案,使客戶能夠加速醫療治療的臨牀開發和商業化,從而改善患者的醫療保健結果。

IQVIA Holdings Inc簡介

公司代碼IQV
公司名稱IQVIA Holdings Inc
上市日期May 09, 2013
CEOMr. Ari Bousbib
員工數量88000
證券類型Ordinary Share
年結日May 09
公司地址2400 Ellis Road
城市DURHAM
上市交易所NYSE Consolidated
國家United States of America
郵編27703
電話19199982000
網址https://ir.iqvia.com/
公司代碼IQV
上市日期May 09, 2013
CEOMr. Ari Bousbib

IQVIA Holdings Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+17.56%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+157.67%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
863.00
-8.87%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
Americas
1.94B
48.17%
Europe & Africa Region
1.24B
30.89%
Asia Pacific Region
841.00M
20.94%
業務
地區
暫無數據

股東統計

更新時間: 10月31日 週五
更新時間: 10月31日 週五
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.40%
Harris Associates L.P.
6.90%
BlackRock Institutional Trust Company, N.A.
5.50%
State Street Investment Management (US)
4.48%
GIC Private Limited
3.84%
其他
67.88%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.40%
Harris Associates L.P.
6.90%
BlackRock Institutional Trust Company, N.A.
5.50%
State Street Investment Management (US)
4.48%
GIC Private Limited
3.84%
其他
67.88%
股東類型
持股股東
佔比
Investment Advisor
48.20%
Investment Advisor/Hedge Fund
34.87%
Hedge Fund
7.16%
Sovereign Wealth Fund
4.96%
Pension Fund
4.16%
Research Firm
2.49%
Bank and Trust
2.06%
Individual Investor
0.91%
Family Office
0.13%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
2061
175.98M
103.33%
-829.63K
2025Q2
2053
166.70M
98.05%
-9.45M
2025Q1
2083
168.53M
97.38%
-9.36M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
2023Q2
1898
167.84M
91.62%
-8.26M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
19.60M
11.53%
-162.29K
-0.82%
Jun 30, 2025
Harris Associates L.P.
11.75M
6.91%
+583.80K
+5.23%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.37M
5.51%
-507.18K
-5.13%
Jun 30, 2025
State Street Investment Management (US)
7.62M
4.49%
-98.36K
-1.27%
Jun 30, 2025
GIC Private Limited
6.54M
3.85%
-2.59M
-28.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.22M
2.48%
-16.90K
-0.40%
Jun 30, 2025
CPP Investments
4.17M
2.45%
-426.35K
-9.28%
Jun 30, 2025
Farallon Capital Management, L.L.C.
3.85M
2.27%
+439.50K
+12.88%
Jun 30, 2025
AllianceBernstein L.P.
3.56M
2.09%
+19.57K
+0.55%
Jun 30, 2025
Artisan Partners Limited Partnership
3.27M
1.93%
+3.27M
--
Jun 30, 2025
查看更多

持股ETF

更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
First Trust Nasdaq Lux Digi Health Solutions ETF
7.97%
Global X HealthTech ETF
5.5%
VanEck Biotech ETF
4.63%
Langar Global HealthTech ETF
4.46%
Adaptive Core ETF
3.04%
iShares Biotechnology ETF
3.03%
iShares ESG Aware MSCI USA Value ETF
2.37%
Invesco Bloomberg Pricing Power ETF
1.96%
American Century Focused Large Cap Value ETF
1.93%
Running Oak Efficient Growth ETF
1.87%
查看更多
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比7.97%
Global X HealthTech ETF
佔比5.5%
VanEck Biotech ETF
佔比4.63%
Langar Global HealthTech ETF
佔比4.46%
Adaptive Core ETF
佔比3.04%
iShares Biotechnology ETF
佔比3.03%
iShares ESG Aware MSCI USA Value ETF
佔比2.37%
Invesco Bloomberg Pricing Power ETF
佔比1.96%
American Century Focused Large Cap Value ETF
佔比1.93%
Running Oak Efficient Growth ETF
佔比1.87%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI